COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:45, il y a 1 année 2 mois Full-year 2024 results: improved profitability and strong cash generation in the second half Exail Technologies excels in 2024 with strong financial performance, record order intake, revenue growth, EBITDA improvement, and debt reduction. Strategic success in defense sector. Perspectives focus on drone systems and defense markets Financial Performance EBITDA Improvement Record Order Intake Exail Technologies Defense Sector
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:30, il y a 1 année 2 mois AIXTRON partner in the GraFunkL research project: use of graphene in UVC LEDs to combat multi-resistant pathogens AIXTRON partners in GraFunkL project using graphene in UVC LEDs to combat multi-resistant pathogens. Project funded by BMBF AIXTRON Graphene Pathogens UVC LEDs GraFunkL
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:30, il y a 1 année 2 mois Steyr Motors AG is considering initial acquisitions to further develop its expansion and profitability alongside strong global organic growth Steyr Motors AG plans initial acquisitions to boost expansion and profitability amid strong organic growth. The Austrian company targets European and Asian markets for new acquisitions Expansion Acquisitions Profitability Organic Growth Steyr Motors AG
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:30, il y a 1 année 2 mois CROSSJECT fait le point sur sa collaboration avec ETON PHARMACEUTICALS, Inc. et sur le programme ZENEO® Hydrocortisone dans le domaine de l'insuffisance surrénale CROSSJECT renforce sa collaboration avec ETON PHARMACEUTICALS pour le programme ZENEO® Hydrocortisone dans l'insuffisance surrénale, avec des depôts de dossiers prévus à partir de S2 2026 Collaboration Eton Pharmaceuticals Crossject Insuffisance Surrénale ZENEO® Hydrocortisone
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:30, il y a 1 année 2 mois CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program CROSSJECT enhances collaboration with ETON PHARMACEUTICALS Inc. on ZENEO adrenal insufficiency program, introducing new hydrocortisone formulation for the hospital market Eton Pharmaceuticals Crossject Hydrocortisone Adrenal Insufficiency ZENEO
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:00, il y a 1 année 2 mois Baloise delivers an operationally successful year and increases its dividend Baloise Holding AG reports operationally successful year with improved core business, increased dividend, and strong cash remittance of CHF 565 million. Annual results show improved combined ratio and higher return on equity Dividend Increase Annual Results Cash Remittance Core Business Baloise Holding AG
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:00, il y a 1 année 2 mois Baloise affiche un exercice fructueux au niveau opérationnel et un dividende en hausse Baloise Holding AG affiche un exercice fructueux au niveau opérationnel avec une hausse du dividende. Les résultats annuels montrent une amélioration du ratio combiné et de la rentabilité des fonds propres Rentabilité Dividende Baloise Fonds Propres Exercice
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:00, il y a 1 année 2 mois Medacta Group SA: Medacta Group SA reports an excellent performance in 2024 with an adjusted EBITDA margin1 in constant currency of 28.0% Medacta Group SA reports excellent 2024 performance with 28.0% adjusted EBITDA margin. Revenue up 16.2% in constant currency. Board proposes CHF 0.69 per share distribution. Outlook targets 13-15% revenue growth & 27% EBITDA margin for 2025 Revenue Growth Adjusted EBITDA Margin Medacta Group SA 2024 Performance 2025 Outlook
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:00, il y a 1 année 2 mois Straumann Group to present its advanced digital dentistry end-to-end workflow at the International Dental Show in Cologne Straumann Group showcases innovative digital dentistry solutions at International Dental Show, introducing Straumann AXS cloud-based platform and partnerships with SprintRay, Carestream Dental. Global launch of iEXCEL implant system and Falcon dynamic navigation solution Straumann Group Digital Dentistry AXS Platform SprintRay Partnership IEXCEL Implant System
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:00, il y a 1 année 2 mois HORNBACH Group delivers successfully in FY 2024/25 – preliminary figures underscore solid performance and relevance for customers HORNBACH Group successfully delivers in FY 2024/25 with solid performance and relevance for customers shown in preliminary figures Customer Satisfaction Preliminary Results HORNBACH Group Market Share Growth FY 2024/25
Publié le 26/05/2026 à 18:39, il y a 12 heures 51 minutes Déclaration des opérations d'achats d'actions réalisées le 18 mai 2026
Publié le 26/05/2026 à 18:39, il y a 12 heures 51 minutes Reporting on share buyback transactions carried out on May 18, 2026
Publié le 26/05/2026 à 17:45, il y a 13 heures 46 minutes EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
Publié le 26/05/2026 à 17:45, il y a 13 heures 46 minutes EURAZEO INVESTIT DANS BABYLON, SPÉCIALISTE FRANÇAIS DES APARTHOTELS DE NOUVELLE GÉNÉRATION
Publié le 26/05/2026 à 17:40, il y a 13 heures 51 minutes LDC : Nombre total de droits de vote et d'actions composant le capital au 30.04.26.
Publié le 27/05/2026 à 02:10, il y a 5 heures 21 minutes Western Investment Company Reports First Quarter 2026 Results and Announces Executive Personnel Changes
Publié le 27/05/2026 à 01:45, il y a 5 heures 46 minutes Organto Foods Announces Record First Quarter 2026 Financial Results
Publié le 27/05/2026 à 00:25, il y a 7 heures 6 minutes Revolve Reports Q3 F2026 Results Backed by Strong Progress Across North American Portfolio
Publié le 26/05/2026 à 22:15, il y a 9 heures 16 minutes LaFleur Announces Bought Deal Equity Offerings for Gross Proceeds of C$8 Million
Publié le 26/05/2026 à 22:01, il y a 9 heures 30 minutes Kidoz Inc. Reports Q1 2026 Financial Results with YoY Revenue Growth, Accelerating Strategic Investment in AI
Publié le 27/05/2026 à 07:29, il y a 2 minutes Aroundtown announces Q1 2026 results in line with guidance. Earnings profile reinforced by successful GCP share-to-share offer and effective capital recycling
Publié le 27/05/2026 à 07:05, il y a 25 minutes USI Showcases Advanced SiC Chip-Embedded Packaging Technology at PCIM Europe 2026
Publié le 27/05/2026 à 07:00, il y a 30 minutes Swiss Life publie le compte d’exploitation 2025 relatif aux affaires LPP
Publié le 27/05/2026 à 06:00, il y a 1 heure 31 minutes Verve Group Reports Solid Organic Growth in the First Quarter, Along with Strong Operating Performance and Significant Cash Flow Growth
Publié le 26/05/2026 à 18:50, il y a 12 heures 40 minutes The AI Gold Rush Is Running Into a Margin Problem